CDH1 and chronic kidney disease: Loss of E-cadherin is consistently observed in tumor malignancy and in many kinds of chronic kidney diseases, such as autosomal dominant polycystic kidney disease (ADPKD) and diabetic nephropathy, resulting in tissue fibrosis [7,20,21].